These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 4976363

  • 1. Industrial production of primary tissue culture.
    Warren J.
    Natl Cancer Inst Monogr; 1968 Dec; 29():35-43. PubMed ID: 4976363
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characteristics of cell culture systems: viral flora of tissue sources and tissue and medium antigens in vaccines--summary.
    Sigel MM, von Magnus H.
    Natl Cancer Inst Monogr; 1968 Dec; 29():551-4. PubMed ID: 4976867
    [No Abstract] [Full Text] [Related]

  • 5. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
    Vasington PJ.
    Natl Cancer Inst Monogr; 1968 Dec; 29():205-6. PubMed ID: 4976358
    [No Abstract] [Full Text] [Related]

  • 6. Tissue and medium antigens in vaccines.
    Coriell LL.
    Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862
    [No Abstract] [Full Text] [Related]

  • 7. Tissue cell cultivation--general comments.
    Pirt SJ.
    Natl Cancer Inst Monogr; 1968 Dec; 29():93-6. PubMed ID: 5720815
    [No Abstract] [Full Text] [Related]

  • 8. Large-scale production of indefinitely propagated cell lines.
    Cooper PD.
    Natl Cancer Inst Monogr; 1968 Dec; 29():63-7. PubMed ID: 5720812
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Latent viral infections in donor tissues and in recipients of vaccines.
    Melnick JL.
    Natl Cancer Inst Monogr; 1968 Dec; 29():337-49. PubMed ID: 4305432
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vaccines produced in heteroploid cell lines--discussion.
    Hull RN.
    Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
    [No Abstract] [Full Text] [Related]

  • 13. Experience with an established cell line for veterinary vaccine production.
    Brown AL.
    Natl Cancer Inst Monogr; 1968 Dec; 29():523-6. PubMed ID: 4305440
    [No Abstract] [Full Text] [Related]

  • 14. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
    Fellowes ON.
    Natl Cancer Inst Monogr; 1968 Dec; 29():209-14. PubMed ID: 5720794
    [No Abstract] [Full Text] [Related]

  • 15. Cell cultures for virus vaccine production. General conclusions from the conference.
    Merchant DJ.
    Natl Cancer Inst Monogr; 1968 Dec; 29():583-4. PubMed ID: 5720811
    [No Abstract] [Full Text] [Related]

  • 16. Detection of latent viruses in kidney tissues.
    Hsiung GD.
    Natl Cancer Inst Monogr; 1968 Dec; 29():351-3. PubMed ID: 4305433
    [No Abstract] [Full Text] [Related]

  • 17. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
    Jensen KE.
    Natl Cancer Inst Monogr; 1968 Dec; 29():207-8. PubMed ID: 5720793
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Viral oncogenicity and viral vaccines--general comments.
    Gerber P.
    Natl Cancer Inst Monogr; 1968 Dec; 29():447-8. PubMed ID: 4888932
    [No Abstract] [Full Text] [Related]

  • 20. Viral flora of primate tissues--discussion.
    Malherbe H.
    Natl Cancer Inst Monogr; 1968 Dec; 29():177-8. PubMed ID: 5720790
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.